'Robbing them': Treasury slams states over Trump tax cuts Experts warn the internet will go down in a big way — and you'd ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...

Air pollution, asthma, COPD & lung care explained by a pulmonologist with simple tips to protect your lungs daily.

Air pollution, particularly fine particulate matter (PM2.5), poses a major threat to our lungs, leading to health issues like ...

IF the festivities have left you frazzled, a rendition of Silent Night could be the perfect antidote. Attending a carol ...

When air quality stays poor for days, the lungs don’t get a break. Even without obvious symptoms, polluted air irritates airways, thickens mucus, and quietly increases inflammation. The body does try ...

In a remarkable medical achievement, doctors in Indore successfully performed a rare and complex lung surgery on 70-year-old ...

Do hot baths improve endurance? Will creatine bolster your brain power? Does pickle juice prevent cramp? Here’s what we learned about living well this year ...

A 40-year-old woman who was a frequent traveler suddenly found herself struggling to breathe after taking just a few steps. What began as unexplained fatigue and shortness of breath quickly disrupted ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...

Among pediatric and adult patients with cystic fibrosis, the average number of chronic respiratory therapies used fell after ...